- Trials with a EudraCT protocol (111)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
111 result(s) found for: Steatosis.
Displaying page 1 of 6.
EudraCT Number: 2005-002966-12 | Sponsor Protocol Number: MD-04-01 | Start Date*: 2005-03-23 | |||||||||||
Sponsor Name:TRASTEC | |||||||||||||
Full Title: PHYSIOPATHOLOGY OF NONALCOHOLIC HEPATIC STEATOSIS AND EFFICACY OF SILYMARIN IN THE THERAPY OF NONALCOHOLIC HEPATIC STEATOSIS | |||||||||||||
Medical condition: Nonalcoholic hepatic steatosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007884-26 | Sponsor Protocol Number: 1.2 (21.11.2007) | Start Date*: 2008-02-13 | ||||||||||||||||
Sponsor Name:HUS, HYKS, Diabetesklinikka | ||||||||||||||||||
Full Title: Pioglitatsonin käyttö potilailla, joilla krooninen rasvamaksasairaus ja tuore tyypin 2 diabetes | ||||||||||||||||||
Medical condition: K76.9 Rasvamaksa E11 Tyypin 2 diabetes | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000499-83 | Sponsor Protocol Number: 1386.4 | Start Date*: 2017-05-04 | |||||||||||
Sponsor Name:Boehringer Ingelheim bv | |||||||||||||
Full Title: A multi-centre, double-blind, parallel-group, randomised, placebo controlled phase II a study to investigate safety, tolerability, pharmacodynamics, and harmacokinetics of different doses of orall... | |||||||||||||
Medical condition: Non-alcoholic steatohepatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) BE (Completed) DE (Completed) IE (Completed) GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003231-46 | Sponsor Protocol Number: 0001 | Start Date*: 2005-11-04 |
Sponsor Name:Dept of Internal Medicine IV, Med Uni Vienna | ||
Full Title: Changes in hepatic lipid content assessed by MR Spectroscopy in patients with non-alcoholic fatty liver disease (NAFLD) under standard therapy (reduction diet and regular aerobic exercise) with and... | ||
Medical condition: Nonalcoholic fatty liver disease (NAFLD) is a potentially progressive liver disease, leading to cirrhosis in up to 26% of affected patients and rarely hepatocellular carcinoma. Several studies have... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-003197-13 | Sponsor Protocol Number: ISIS484137-CS2 | Start Date*: 2017-11-24 | ||||||||||||||||
Sponsor Name:Ionis Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Pharmacodynamics of ISIS 484137 (ISIS-DGAT2RX, an Antisense Inhibitor of Diacylglycerol Acyltr... | ||||||||||||||||||
Medical condition: Hepatic Steatosis in type 2 diabetes (T2DM) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-004449-18 | Sponsor Protocol Number: HEP201 | Start Date*: 2019-04-10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Promethera Biosciences | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Multicenter, open-label, safety and tolerability study of ascending doses of HepaStem in patients with cirrhotic and pre-cirrhotic non-alcoholic steatohepatitis (NASH). | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: NASH is characterized by steatosis, inflammation and cytological ballooning with varying amounts of fibrosis. Patients with NASH are at risk of cardiovascular morbidity and mortality. In chronic li... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: FR (Completed) BE (Completed) BG (Completed) PL (Completed) ES (Ongoing) RO (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-004986-38 | Sponsor Protocol Number: 337HNAS20011 | Start Date*: 2022-01-04 | |||||||||||
Sponsor Name:Inventiva S.A. | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, multicentre, Phase 3 study evaluating long-term efficacy and safety of lanifibranor in adult patients with non-cirrhotic non-alcoholic steatohepatiti... | |||||||||||||
Medical condition: Non-alcoholic Steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) DE (Ongoing) ES (Ongoing) AT (Completed) HU (Ongoing) BG (Ongoing) IT (Ongoing) NL (Ongoing) PL (Ongoing) BE (Ongoing) PT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004515-56 | Sponsor Protocol Number: hepatology_MT_2007-08 | Start Date*: 2008-04-28 |
Sponsor Name:Klinische Abteilung für Gastroenterologie und Hepatologie, Medizinische Universitätsklinik, MUG | ||
Full Title: Efficacy of ursodeoxycholic acid in the treatment of insulin resistance and vascular dysfunction in non-alcoholic fatty liver disease | ||
Medical condition: Non-alcoholic fatty liver disease (NAFLD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2012-002564-27 | Sponsor Protocol Number: STH16037 | Start Date*: 2013-01-31 |
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | ||
Full Title: Pilot open study of testosterone replacement in non-alcoholic steatohepatitis | ||
Medical condition: Non alcoholic fatty liver disease (NAFLD) in men with low serum testosterone levels | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001979-70 | Sponsor Protocol Number: IVA_01_337_HNAS_16_002 | Start Date*: 2017-01-23 | |||||||||||
Sponsor Name:Inventiva S.A. | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, multicenter, dose-range, proof-of-concept, 24-week treatment study of IVA337 in adult subjects with nonalcoholic steatohepatitis (NASH) | |||||||||||||
Medical condition: Nonalcoholic steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) CZ (Completed) AT (Completed) PT (Completed) ES (Completed) NL (Completed) PL (Completed) FR (Completed) BG (Completed) SI (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-006165-18 | Sponsor Protocol Number: FEN | Start Date*: 2012-06-20 |
Sponsor Name:Academic Medical Center | ||
Full Title: A randomized double blind placebo controlled study on the effects of fenretinide Lym-X-Sorb on insulin sensitivity in obese insulin resistant subjects | ||
Medical condition: Obesity Metabolic syndrome X Insulin resistance Fatty liver | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000203-82 | Sponsor Protocol Number: SHP626-201 | Start Date*: 2016-11-09 | |||||||||||
Sponsor Name:Shire Human Genetic Therapies, Inc. | |||||||||||||
Full Title: A Phase 2 Double-Blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter... | |||||||||||||
Medical condition: Nonalcoholic steatohepatitis (NASH), is a clinical condition occurring in individuals who do not drink excessive alcohol (>20 grams/day), yet have hepatic histology which is indistinguishable from ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000295-42 | Sponsor Protocol Number: GFT505-212-7 | Start Date*: 2012-09-11 | |||||||||||
Sponsor Name:GENFIT | |||||||||||||
Full Title: A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 once daily on Steatohepatitis in Patients with Non-Alcoholic Steatohepatitis (NASH). | |||||||||||||
Medical condition: Patients with Non-Alcoholic Steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) ES (Completed) GB (Completed) NL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001010-34 | Sponsor Protocol Number: G-LUCAS | Start Date*: 2011-11-08 |
Sponsor Name:ABCSG (Austrian Breast & Colorectal Cancer Study Group) | ||
Full Title: A randomized, placebo-controlled, double-blind multicenter phase II study to investigate the protectivity and efficacy of Metformin against steatosis in combination with FOLFIRI and Cetuximab in su... | ||
Medical condition: first-line palliative treated, KRAS-Wild-Type, metastatic colorectal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-005531-28 | Sponsor Protocol Number: Urso in Obese | Start Date*: 2008-04-03 | |||||||||||
Sponsor Name:Hanns-Ulrich Marschall | |||||||||||||
Full Title: Ursodeoxycholic Acid in Morbidly Obese Patients Before Bariatric Surgery | |||||||||||||
Medical condition: Patients with morbid obesity (MB) are investigated. MB is very frequently (90%) associated with non-alcoholic fatty liver disease (NAFLD) comprising a spectrum reaching from steatosis (NAFL) over s... | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003010-17 | Sponsor Protocol Number: - | Start Date*: 2011-07-07 | |||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: Randomized double-blind intervention trial to assess the efficacy of vitamin D3 supplementation vs placebo in reducing hepatic steato-inflammation and cardio-metabolic risk profile in patients affe... | |||||||||||||
Medical condition: Patients affected by type 2 diabetes and non alcoholic fatty liver disease- non alcoholic steato-hepatitis (NAFLD/NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001987-31 | Sponsor Protocol Number: COMBAT_T2_NASH_002 | Start Date*: 2020-08-05 | |||||||||||
Sponsor Name:Deutsche Diabetes Forschungsgesellschaft e.V. | |||||||||||||
Full Title: COMBined Active Treatment in Type 2 Diabetes with NASH | |||||||||||||
Medical condition: Diabetes mellitus type 2 (T2D) and non-alcoholic steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004999-19 | Sponsor Protocol Number: 191001 | Start Date*: 2020-06-16 | |||||||||||
Sponsor Name:Department of infectious diseases, Hvidovre Hospital | |||||||||||||
Full Title: Changes in weight, body composition and metabolic parameters after switch to dolutegravir/lamuvidine compared to continued treatment with dolutegravir/abacavir/lamuvidine for virologically suppress... | |||||||||||||
Medical condition: Human immunodeficiency viruses (HIV) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003901-23 | Sponsor Protocol Number: K-001-201 | Start Date*: 2022-05-11 | |||||||||||
Sponsor Name:Kowa Research Institute, Inc | |||||||||||||
Full Title: A Phase 2, Multicenter, Placebo-Controlled, Randomized, Double-Blind, 48-Week Study to Evaluate the Efficacy and Safety of Combination Therapy of K-877-ER and CSG452 in Patients with Noncirrhotic N... | |||||||||||||
Medical condition: Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Liver Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) BG (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000860-24 | Sponsor Protocol Number: IBI 12.05 | Start Date*: 2005-11-15 | |||||||||||
Sponsor Name:IBI | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled trial on the efficacy of 12 months of treatment with Realsil in subjects with hipertransaminasemia and steatosis or non-alcoholic steatohepatitis with... | |||||||||||||
Medical condition: Subjects with hipertransaminasemia and steatosis or non-alcoholic steatohepatitis with or without HCV infection. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.